P2.10. Liquid Biopsy-based Umbrella Trial for Advanced NSCLC: Results of Phase 2 Plasma ALK-positive Cohort (A-Liquid) - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Yuki Nakatani
Meta Tag
Speaker Yuki Nakatani
Topic Metastatic NSCLC: Targeted Therapy - FUSIONS
non-small cell carcinoma
liquid next-generation sequencing
umbrella trial
oncogene alterations
ALK inhibitor-naïve patients
objective response rate
progression-free survival
overall survival
Powered By